University of Rochester Medical Center Wilmot Cancer Center
Strong Memorial Hospital
Rochester, NY
Accepting patients
Safety Study of Cord Blood Units
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
- Allogeneic Stem Cell Transplant
- Phase 2
Accepting patients
HBO-UBC
A Randomized Phase II Study Evaluating the Efficacy of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplantation
- Cord Blood
- Phase 2
Accepting patients
Umbilical Cord Blood Transplantation
Umbilical Cord Blood Transplantation From Unrelated Donors
- Cord Blood
- Phase 1
Accepting patients
MyeloMATCH Master Protocol
Master Screening and Reassessment Protocol (MSRP) for the NCI MyeloMATCH Clinical Trials
- Genetic Sequencing
- Phase 2
Accepting patients
MRD
A Program for Monitoring Minimal Residual Disease Following Treatment of Patients With Acute Myeloid Leukemia or High Grade Myelodysplastic Syndrome
- Minimal Residual Disease (MRD)
Accepting patients
Hyperbaric Oxygen Therapy
A Pilot Study to Determine the Safety and Efficacy of Incorporating Hyperbaric Oxygen Therapy Into RIC Fludarabine and Melphalan and Allogeneic Hematopoietic Stem/Progenitor Transplantation
- Allogeneic Stem Cell Transplant
- Phase 1
Accepting patients
Phase 1/2 Multicenter, Open-Label Study of CTX-712 in Patients With Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
- CLK Inhibitor
- Phase 1/2
Accepting patients
TeleSICP
A Telehealth Advance Care Planning Intervention for Older Patients With Myeloid Malignancies: A Pilot Randomized Controlled Trial
- Phase 1
Accepting patients
ABNL-MARRO
The ABNL-MARRO 001 Study: A Phase 1/2 Study of Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes.
- Chemotherapy
- Phase 1/2
- Has results